BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Vancouver
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220223T040000
DTEND;TZID=America/Vancouver:20220223T050000
DTSTAMP:20260619T050422
CREATED:20220222T060729Z
LAST-MODIFIED:20220222T060729Z
UID:20867-1645588800-1645592400@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: Harnessing the Power of Excess Statistical Significance
DESCRIPTION:About the topic: In this presentation\, Tom Stanley will show how excess statistical significance (ESS) can improve the credibility of research synthesis. This will generalize on the notion of an excess of statistical significance by Ioannidis & Trikalinos’ (2007) that formed the basis for their chi-square test for publication bias by accommodating heterogeneity. This version of ESS leads to several new tests for publication selection bias (PSB) that are better than the alternatives as well as a new estimator of mean effect (WILS) that greatly reduces bias and MSE at virtually no cost to efficiency. These methods do not depend on the mechanism or the model of publication selection bias. The findings of these methods cannot be dismissed as a small-study effect because they do not treat small studies differently than large studies nor use\, in any way\, the correlation of effect size with its SE. Mathematically\, PSB→E(ESS) > 0; hence\, ESS serves as a good indicator of PSB. \nAbout the speaker: Tom Stanley is Professor of Meta-Analysis at the School of Business and Law\, Deakin University\, Melbourne Australia. For over 30 years\, Tom taught various economics and statistics classes at Hendrix College\, as well as the odd history class (e.g.\, Western Intellectual Traditions). Since the 1980s\, his research has focused on the development and application of meta-regression methods and the mitigation of publication bias. Prof. Stanley is the convener of MAER-Net (Meta-Analysis of Economics Research Network) and a member of both DeLMAR (Deakin Lab for the Meta-Analysis of Research) and the Society for Research Synthesis Methods. He is Associate Editor of the Journal of Economic Surveys and Research Synthesis Methods.
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-harnessing-the-power-of-excess-statistical-significance/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220223T040000
DTEND;TZID=America/Vancouver:20220223T050000
DTSTAMP:20260619T050422
CREATED:20220222T060729Z
LAST-MODIFIED:20220222T060729Z
UID:26510-1645588800-1645592400@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: Harnessing the Power of Excess Statistical Significance
DESCRIPTION:About the topic: In this presentation\, Tom Stanley will show how excess statistical significance (ESS) can improve the credibility of research synthesis. This will generalize on the notion of an excess of statistical significance by Ioannidis & Trikalinos’ (2007) that formed the basis for their chi-square test for publication bias by accommodating heterogeneity. This version of ESS leads to several new tests for publication selection bias (PSB) that are better than the alternatives as well as a new estimator of mean effect (WILS) that greatly reduces bias and MSE at virtually no cost to efficiency. These methods do not depend on the mechanism or the model of publication selection bias. The findings of these methods cannot be dismissed as a small-study effect because they do not treat small studies differently than large studies nor use\, in any way\, the correlation of effect size with its SE. Mathematically\, PSB→E(ESS) > 0; hence\, ESS serves as a good indicator of PSB. \nAbout the speaker: Tom Stanley is Professor of Meta-Analysis at the School of Business and Law\, Deakin University\, Melbourne Australia. For over 30 years\, Tom taught various economics and statistics classes at Hendrix College\, as well as the odd history class (e.g.\, Western Intellectual Traditions). Since the 1980s\, his research has focused on the development and application of meta-regression methods and the mitigation of publication bias. Prof. Stanley is the convener of MAER-Net (Meta-Analysis of Economics Research Network) and a member of both DeLMAR (Deakin Lab for the Meta-Analysis of Research) and the Society for Research Synthesis Methods. He is Associate Editor of the Journal of Economic Surveys and Research Synthesis Methods.
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-harnessing-the-power-of-excess-statistical-significance-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220223T040000
DTEND;TZID=America/Vancouver:20220223T050000
DTSTAMP:20260619T050422
CREATED:20220222T060729Z
LAST-MODIFIED:20220222T060729Z
UID:28125-1645588800-1645592400@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: Harnessing the Power of Excess Statistical Significance
DESCRIPTION:About the topic: In this presentation\, Tom Stanley will show how excess statistical significance (ESS) can improve the credibility of research synthesis. This will generalize on the notion of an excess of statistical significance by Ioannidis & Trikalinos’ (2007) that formed the basis for their chi-square test for publication bias by accommodating heterogeneity. This version of ESS leads to several new tests for publication selection bias (PSB) that are better than the alternatives as well as a new estimator of mean effect (WILS) that greatly reduces bias and MSE at virtually no cost to efficiency. These methods do not depend on the mechanism or the model of publication selection bias. The findings of these methods cannot be dismissed as a small-study effect because they do not treat small studies differently than large studies nor use\, in any way\, the correlation of effect size with its SE. Mathematically\, PSB→E(ESS) > 0; hence\, ESS serves as a good indicator of PSB. \nAbout the speaker: Tom Stanley is Professor of Meta-Analysis at the School of Business and Law\, Deakin University\, Melbourne Australia. For over 30 years\, Tom taught various economics and statistics classes at Hendrix College\, as well as the odd history class (e.g.\, Western Intellectual Traditions). Since the 1980s\, his research has focused on the development and application of meta-regression methods and the mitigation of publication bias. Prof. Stanley is the convener of MAER-Net (Meta-Analysis of Economics Research Network) and a member of both DeLMAR (Deakin Lab for the Meta-Analysis of Research) and the Society for Research Synthesis Methods. He is Associate Editor of the Journal of Economic Surveys and Research Synthesis Methods.
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-harnessing-the-power-of-excess-statistical-significance-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220223T040000
DTEND;TZID=America/Vancouver:20220223T050000
DTSTAMP:20260619T050422
CREATED:20220222T060729Z
LAST-MODIFIED:20220222T060729Z
UID:31208-1645588800-1645592400@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: Harnessing the Power of Excess Statistical Significance
DESCRIPTION:About the topic: In this presentation\, Tom Stanley will show how excess statistical significance (ESS) can improve the credibility of research synthesis. This will generalize on the notion of an excess of statistical significance by Ioannidis & Trikalinos’ (2007) that formed the basis for their chi-square test for publication bias by accommodating heterogeneity. This version of ESS leads to several new tests for publication selection bias (PSB) that are better than the alternatives as well as a new estimator of mean effect (WILS) that greatly reduces bias and MSE at virtually no cost to efficiency. These methods do not depend on the mechanism or the model of publication selection bias. The findings of these methods cannot be dismissed as a small-study effect because they do not treat small studies differently than large studies nor use\, in any way\, the correlation of effect size with its SE. Mathematically\, PSB→E(ESS) > 0; hence\, ESS serves as a good indicator of PSB. \nAbout the speaker: Tom Stanley is Professor of Meta-Analysis at the School of Business and Law\, Deakin University\, Melbourne Australia. For over 30 years\, Tom taught various economics and statistics classes at Hendrix College\, as well as the odd history class (e.g.\, Western Intellectual Traditions). Since the 1980s\, his research has focused on the development and application of meta-regression methods and the mitigation of publication bias. Prof. Stanley is the convener of MAER-Net (Meta-Analysis of Economics Research Network) and a member of both DeLMAR (Deakin Lab for the Meta-Analysis of Research) and the Society for Research Synthesis Methods. He is Associate Editor of the Journal of Economic Surveys and Research Synthesis Methods.
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-harnessing-the-power-of-excess-statistical-significance-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220223T040000
DTEND;TZID=America/Vancouver:20220223T050000
DTSTAMP:20260619T050422
CREATED:20220222T060729Z
LAST-MODIFIED:20220222T060729Z
UID:32668-1645588800-1645592400@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: Harnessing the Power of Excess Statistical Significance
DESCRIPTION:About the topic: In this presentation\, Tom Stanley will show how excess statistical significance (ESS) can improve the credibility of research synthesis. This will generalize on the notion of an excess of statistical significance by Ioannidis & Trikalinos’ (2007) that formed the basis for their chi-square test for publication bias by accommodating heterogeneity. This version of ESS leads to several new tests for publication selection bias (PSB) that are better than the alternatives as well as a new estimator of mean effect (WILS) that greatly reduces bias and MSE at virtually no cost to efficiency. These methods do not depend on the mechanism or the model of publication selection bias. The findings of these methods cannot be dismissed as a small-study effect because they do not treat small studies differently than large studies nor use\, in any way\, the correlation of effect size with its SE. Mathematically\, PSB→E(ESS) > 0; hence\, ESS serves as a good indicator of PSB. \nAbout the speaker: Tom Stanley is Professor of Meta-Analysis at the School of Business and Law\, Deakin University\, Melbourne Australia. For over 30 years\, Tom taught various economics and statistics classes at Hendrix College\, as well as the odd history class (e.g.\, Western Intellectual Traditions). Since the 1980s\, his research has focused on the development and application of meta-regression methods and the mitigation of publication bias. Prof. Stanley is the convener of MAER-Net (Meta-Analysis of Economics Research Network) and a member of both DeLMAR (Deakin Lab for the Meta-Analysis of Research) and the Society for Research Synthesis Methods. He is Associate Editor of the Journal of Economic Surveys and Research Synthesis Methods.
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-harnessing-the-power-of-excess-statistical-significance-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220223T130000
DTEND;TZID=America/Vancouver:20220223T160000
DTSTAMP:20260619T050422
CREATED:20211217T222620Z
LAST-MODIFIED:20220222T172308Z
UID:19909-1645621200-1645632000@scienceinvancouver.com
SUMMARY:Three Minute Thesis: VCHRI and UBC Heat
DESCRIPTION:Join us for the VCHRI and UBC Faculty of Medicine Heat of Three Minute Thesis (3MT). 3MT is an academic competition for current graduate students who will have just three minutes to explain the breadth and significance of their research project to a lay audience. Department heats will be held across campus beginning in February\, with winners moving on to the UBC-wide semi-finals and finals in March. \nVisit the UBC 3MT website for the competition schedule and additional information. \nNote: We are carefully watching the developing situation with the Omicron variant of COVID-19. Please be prepared to attend this event via Zoom. We will let you know via email once the location (in-person or virtual) has been confirmed.
URL:https://scienceinvancouver.com/event/three-minute-thesis-vchri-and-ubc-heat/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220223T130000
DTEND;TZID=America/Vancouver:20220223T160000
DTSTAMP:20260619T050422
CREATED:20211217T222620Z
LAST-MODIFIED:20211217T222620Z
UID:26490-1645621200-1645632000@scienceinvancouver.com
SUMMARY:Three Minute Thesis: VCHRI and UBC Heat
DESCRIPTION:Join us for the VCHRI and UBC Faculty of Medicine Heat of Three Minute Thesis (3MT). 3MT is an academic competition for current graduate students who will have just three minutes to explain the breadth and significance of their research project to a lay audience. Department heats will be held across campus beginning in February\, with winners moving on to the UBC-wide semi-finals and finals in March. \nVisit the UBC 3MT website for the competition schedule and additional information. \nNote: We are carefully watching the developing situation with the Omicron variant of COVID-19. Please be prepared to attend this event via Zoom. We will let you know via email once the location (in-person or virtual) has been confirmed.
URL:https://scienceinvancouver.com/event/three-minute-thesis-vchri-and-ubc-heat-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220223T130000
DTEND;TZID=America/Vancouver:20220223T160000
DTSTAMP:20260619T050422
CREATED:20211217T222620Z
LAST-MODIFIED:20211217T222620Z
UID:28105-1645621200-1645632000@scienceinvancouver.com
SUMMARY:Three Minute Thesis: VCHRI and UBC Heat
DESCRIPTION:Join us for the VCHRI and UBC Faculty of Medicine Heat of Three Minute Thesis (3MT). 3MT is an academic competition for current graduate students who will have just three minutes to explain the breadth and significance of their research project to a lay audience. Department heats will be held across campus beginning in February\, with winners moving on to the UBC-wide semi-finals and finals in March. \nVisit the UBC 3MT website for the competition schedule and additional information. \nNote: We are carefully watching the developing situation with the Omicron variant of COVID-19. Please be prepared to attend this event via Zoom. We will let you know via email once the location (in-person or virtual) has been confirmed.
URL:https://scienceinvancouver.com/event/three-minute-thesis-vchri-and-ubc-heat-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220223T130000
DTEND;TZID=America/Vancouver:20220223T160000
DTSTAMP:20260619T050422
CREATED:20211217T222620Z
LAST-MODIFIED:20211217T222620Z
UID:31188-1645621200-1645632000@scienceinvancouver.com
SUMMARY:Three Minute Thesis: VCHRI and UBC Heat
DESCRIPTION:Join us for the VCHRI and UBC Faculty of Medicine Heat of Three Minute Thesis (3MT). 3MT is an academic competition for current graduate students who will have just three minutes to explain the breadth and significance of their research project to a lay audience. Department heats will be held across campus beginning in February\, with winners moving on to the UBC-wide semi-finals and finals in March. \nVisit the UBC 3MT website for the competition schedule and additional information. \nNote: We are carefully watching the developing situation with the Omicron variant of COVID-19. Please be prepared to attend this event via Zoom. We will let you know via email once the location (in-person or virtual) has been confirmed.
URL:https://scienceinvancouver.com/event/three-minute-thesis-vchri-and-ubc-heat-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220223T130000
DTEND;TZID=America/Vancouver:20220223T160000
DTSTAMP:20260619T050422
CREATED:20211217T222620Z
LAST-MODIFIED:20211217T222620Z
UID:32648-1645621200-1645632000@scienceinvancouver.com
SUMMARY:Three Minute Thesis: VCHRI and UBC Heat
DESCRIPTION:Join us for the VCHRI and UBC Faculty of Medicine Heat of Three Minute Thesis (3MT). 3MT is an academic competition for current graduate students who will have just three minutes to explain the breadth and significance of their research project to a lay audience. Department heats will be held across campus beginning in February\, with winners moving on to the UBC-wide semi-finals and finals in March. \nVisit the UBC 3MT website for the competition schedule and additional information. \nNote: We are carefully watching the developing situation with the Omicron variant of COVID-19. Please be prepared to attend this event via Zoom. We will let you know via email once the location (in-person or virtual) has been confirmed.
URL:https://scienceinvancouver.com/event/three-minute-thesis-vchri-and-ubc-heat-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220224T030000
DTEND;TZID=America/Vancouver:20220224T040000
DTSTAMP:20260619T050422
CREATED:20220222T190530Z
LAST-MODIFIED:20220222T190530Z
UID:20898-1645671600-1645675200@scienceinvancouver.com
SUMMARY:SBME Virtual Seminar: Marina Nysten
DESCRIPTION:Talk: Understanding Market Access in Canada\nOverview: \nBiomedical engineers and researchers work to make life-changing medical discoveries every day. But what happens after a drug is developed and proven clinically effective? Our discoveries are only as important as their potential to impact the end users who need them the most. How does a clinically approved drug get into the hands of patients?\nIn this seminar\, we’ll hear insights and insider knowledge from a former Johnson & Johnson Market Access team member. Whether you’re working towards medical drug development or want to learn more about the whole lab-to-market road\, join a former to understand drug market access in Canada.
URL:https://scienceinvancouver.com/event/sbme-virtual-seminar-marina-nysten/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220224T030000
DTEND;TZID=America/Vancouver:20220224T040000
DTSTAMP:20260619T050422
CREATED:20220222T190530Z
LAST-MODIFIED:20220222T190530Z
UID:26513-1645671600-1645675200@scienceinvancouver.com
SUMMARY:SBME Virtual Seminar: Marina Nysten
DESCRIPTION:Talk: Understanding Market Access in Canada\nOverview: \nBiomedical engineers and researchers work to make life-changing medical discoveries every day. But what happens after a drug is developed and proven clinically effective? Our discoveries are only as important as their potential to impact the end users who need them the most. How does a clinically approved drug get into the hands of patients?\nIn this seminar\, we’ll hear insights and insider knowledge from a former Johnson & Johnson Market Access team member. Whether you’re working towards medical drug development or want to learn more about the whole lab-to-market road\, join a former to understand drug market access in Canada.
URL:https://scienceinvancouver.com/event/sbme-virtual-seminar-marina-nysten-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220224T030000
DTEND;TZID=America/Vancouver:20220224T040000
DTSTAMP:20260619T050422
CREATED:20220222T190530Z
LAST-MODIFIED:20220222T190530Z
UID:28128-1645671600-1645675200@scienceinvancouver.com
SUMMARY:SBME Virtual Seminar: Marina Nysten
DESCRIPTION:Talk: Understanding Market Access in Canada\nOverview: \nBiomedical engineers and researchers work to make life-changing medical discoveries every day. But what happens after a drug is developed and proven clinically effective? Our discoveries are only as important as their potential to impact the end users who need them the most. How does a clinically approved drug get into the hands of patients?\nIn this seminar\, we’ll hear insights and insider knowledge from a former Johnson & Johnson Market Access team member. Whether you’re working towards medical drug development or want to learn more about the whole lab-to-market road\, join a former to understand drug market access in Canada.
URL:https://scienceinvancouver.com/event/sbme-virtual-seminar-marina-nysten-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220224T030000
DTEND;TZID=America/Vancouver:20220224T040000
DTSTAMP:20260619T050422
CREATED:20220222T190530Z
LAST-MODIFIED:20220222T190530Z
UID:31211-1645671600-1645675200@scienceinvancouver.com
SUMMARY:SBME Virtual Seminar: Marina Nysten
DESCRIPTION:Talk: Understanding Market Access in Canada\nOverview: \nBiomedical engineers and researchers work to make life-changing medical discoveries every day. But what happens after a drug is developed and proven clinically effective? Our discoveries are only as important as their potential to impact the end users who need them the most. How does a clinically approved drug get into the hands of patients?\nIn this seminar\, we’ll hear insights and insider knowledge from a former Johnson & Johnson Market Access team member. Whether you’re working towards medical drug development or want to learn more about the whole lab-to-market road\, join a former to understand drug market access in Canada.
URL:https://scienceinvancouver.com/event/sbme-virtual-seminar-marina-nysten-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220224T030000
DTEND;TZID=America/Vancouver:20220224T040000
DTSTAMP:20260619T050422
CREATED:20220222T190530Z
LAST-MODIFIED:20220222T190530Z
UID:32671-1645671600-1645675200@scienceinvancouver.com
SUMMARY:SBME Virtual Seminar: Marina Nysten
DESCRIPTION:Talk: Understanding Market Access in Canada\nOverview: \nBiomedical engineers and researchers work to make life-changing medical discoveries every day. But what happens after a drug is developed and proven clinically effective? Our discoveries are only as important as their potential to impact the end users who need them the most. How does a clinically approved drug get into the hands of patients?\nIn this seminar\, we’ll hear insights and insider knowledge from a former Johnson & Johnson Market Access team member. Whether you’re working towards medical drug development or want to learn more about the whole lab-to-market road\, join a former to understand drug market access in Canada.
URL:https://scienceinvancouver.com/event/sbme-virtual-seminar-marina-nysten-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220225T040000
DTEND;TZID=America/Vancouver:20220225T063000
DTSTAMP:20260619T050422
CREATED:20220221T204204Z
LAST-MODIFIED:20220222T173310Z
UID:20855-1645761600-1645770600@scienceinvancouver.com
SUMMARY:Praxis SCI Incubate Demo Day 2022
DESCRIPTION:Learn about some of the most cutting-edge medical technologies in the market. Meet the ENTREPRENEURS changing the future of care for spinal cord injury (SCI)\, and discover what it takes to move your innovation to the next level.\n\nDemo Day is a rare opportunity to hear from individuals living with SCI and today’s industry experts. \nPre-event highlights \n\nOpening remarks by Dan Coulter\, MLA\, Parliamentary Secretary for Accessibility\nLearn more about the current cohort and watch live feedback from our guest judging panel on their investment pitches\nConfirmed panelists include:\n\nJennifer French\, Founder and Executive Director of Neurotech Network\nAlex Arevalos\, CEO and Cofounder of Starling Medical\, member of SCI Incubate 2020 cohort\nRichard Toselli\, President\, CEO and Chief Medical Officer of InVivo Therapeutics
URL:https://scienceinvancouver.com/event/praxis-sci-incubate-demo-day-2022/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/02/SCIincubateDemoDay2022_graphics_postcard-02-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220225T040000
DTEND;TZID=America/Vancouver:20220225T063000
DTSTAMP:20260619T050422
CREATED:20220221T204204Z
LAST-MODIFIED:20220221T204204Z
UID:26508-1645761600-1645770600@scienceinvancouver.com
SUMMARY:Praxis SCI Incubate Demo Day 2022
DESCRIPTION:Learn about some of the most cutting-edge medical technologies in the market. Meet the ENTREPRENEURS changing the future of care for spinal cord injury (SCI)\, and discover what it takes to move your innovation to the next level.\n\nDemo Day is a rare opportunity to hear from individuals living with SCI and today’s industry experts. \nPre-event highlights \n\nOpening remarks by Dan Coulter\, MLA\, Parliamentary Secretary for Accessibility\nLearn more about the current cohort and watch live feedback from our guest judging panel on their investment pitches\nConfirmed panelists include:\n\nJennifer French\, Founder and Executive Director of Neurotech Network\nAlex Arevalos\, CEO and Cofounder of Starling Medical\, member of SCI Incubate 2020 cohort\nRichard Toselli\, President\, CEO and Chief Medical Officer of InVivo Therapeutics
URL:https://scienceinvancouver.com/event/praxis-sci-incubate-demo-day-2022-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/02/SCIincubateDemoDay2022_graphics_postcard-02-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220225T040000
DTEND;TZID=America/Vancouver:20220225T063000
DTSTAMP:20260619T050422
CREATED:20220221T204204Z
LAST-MODIFIED:20220221T204204Z
UID:28123-1645761600-1645770600@scienceinvancouver.com
SUMMARY:Praxis SCI Incubate Demo Day 2022
DESCRIPTION:Learn about some of the most cutting-edge medical technologies in the market. Meet the ENTREPRENEURS changing the future of care for spinal cord injury (SCI)\, and discover what it takes to move your innovation to the next level.\n\nDemo Day is a rare opportunity to hear from individuals living with SCI and today’s industry experts. \nPre-event highlights \n\nOpening remarks by Dan Coulter\, MLA\, Parliamentary Secretary for Accessibility\nLearn more about the current cohort and watch live feedback from our guest judging panel on their investment pitches\nConfirmed panelists include:\n\nJennifer French\, Founder and Executive Director of Neurotech Network\nAlex Arevalos\, CEO and Cofounder of Starling Medical\, member of SCI Incubate 2020 cohort\nRichard Toselli\, President\, CEO and Chief Medical Officer of InVivo Therapeutics
URL:https://scienceinvancouver.com/event/praxis-sci-incubate-demo-day-2022-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/02/SCIincubateDemoDay2022_graphics_postcard-02-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220225T040000
DTEND;TZID=America/Vancouver:20220225T063000
DTSTAMP:20260619T050422
CREATED:20220221T204204Z
LAST-MODIFIED:20220221T204204Z
UID:31206-1645761600-1645770600@scienceinvancouver.com
SUMMARY:Praxis SCI Incubate Demo Day 2022
DESCRIPTION:Learn about some of the most cutting-edge medical technologies in the market. Meet the ENTREPRENEURS changing the future of care for spinal cord injury (SCI)\, and discover what it takes to move your innovation to the next level.\n\nDemo Day is a rare opportunity to hear from individuals living with SCI and today’s industry experts. \nPre-event highlights \n\nOpening remarks by Dan Coulter\, MLA\, Parliamentary Secretary for Accessibility\nLearn more about the current cohort and watch live feedback from our guest judging panel on their investment pitches\nConfirmed panelists include:\n\nJennifer French\, Founder and Executive Director of Neurotech Network\nAlex Arevalos\, CEO and Cofounder of Starling Medical\, member of SCI Incubate 2020 cohort\nRichard Toselli\, President\, CEO and Chief Medical Officer of InVivo Therapeutics
URL:https://scienceinvancouver.com/event/praxis-sci-incubate-demo-day-2022-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/02/SCIincubateDemoDay2022_graphics_postcard-02-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220225T040000
DTEND;TZID=America/Vancouver:20220225T063000
DTSTAMP:20260619T050422
CREATED:20220221T204204Z
LAST-MODIFIED:20220221T204204Z
UID:32666-1645761600-1645770600@scienceinvancouver.com
SUMMARY:Praxis SCI Incubate Demo Day 2022
DESCRIPTION:Learn about some of the most cutting-edge medical technologies in the market. Meet the ENTREPRENEURS changing the future of care for spinal cord injury (SCI)\, and discover what it takes to move your innovation to the next level.\n\nDemo Day is a rare opportunity to hear from individuals living with SCI and today’s industry experts. \nPre-event highlights \n\nOpening remarks by Dan Coulter\, MLA\, Parliamentary Secretary for Accessibility\nLearn more about the current cohort and watch live feedback from our guest judging panel on their investment pitches\nConfirmed panelists include:\n\nJennifer French\, Founder and Executive Director of Neurotech Network\nAlex Arevalos\, CEO and Cofounder of Starling Medical\, member of SCI Incubate 2020 cohort\nRichard Toselli\, President\, CEO and Chief Medical Officer of InVivo Therapeutics
URL:https://scienceinvancouver.com/event/praxis-sci-incubate-demo-day-2022-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/02/SCIincubateDemoDay2022_graphics_postcard-02-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220301T020000
DTEND;TZID=America/Vancouver:20220301T033000
DTSTAMP:20260619T050422
CREATED:20220222T210720Z
LAST-MODIFIED:20220222T210720Z
UID:20901-1646100000-1646105400@scienceinvancouver.com
SUMMARY:Genome Canada Genomic Applications Partnership Program Information Session
DESCRIPTION:The latest round of the Genome Canada Genomic Applications Partnership Program (GAPP) has launched and Genome BC\, in partnership with VPRI\, will host an Information Session in support of it. \nGAPP funds downstream research and development projects that address real world opportunities and challenges identified by industry\, government\, not-for-profits and other “Receptors” of genomics knowledge and technologies. GAPP projects are collaborations between academic researchers and Receptor organizations and are funded by Genome Canada and co-funded by Receptors and other stakeholders. \nGenome BC staff will deliver a brief presentation on the competition followed by a Q&A session. Interested applicants will have the opportunity to have one-on-one conversations with Genome BC staff to help develop ideas. \nThe webinar will be delivered via Zoom and all interested UBC faculty\, support staff and partners are invited to attend. \nDetails: \n\nTuesday\, March 1\, 10-11:30am\nA Zoom link will be sent to registrants before the session\n\nGenome BC Contact: Alison Dendoff\nSPARC Contact: Alex Unterberger
URL:https://scienceinvancouver.com/event/genome-canada-genomic-applications-partnership-program-information-session/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220301T020000
DTEND;TZID=America/Vancouver:20220301T033000
DTSTAMP:20260619T050422
CREATED:20220222T210720Z
LAST-MODIFIED:20220222T210720Z
UID:26514-1646100000-1646105400@scienceinvancouver.com
SUMMARY:Genome Canada Genomic Applications Partnership Program Information Session
DESCRIPTION:The latest round of the Genome Canada Genomic Applications Partnership Program (GAPP) has launched and Genome BC\, in partnership with VPRI\, will host an Information Session in support of it. \nGAPP funds downstream research and development projects that address real world opportunities and challenges identified by industry\, government\, not-for-profits and other “Receptors” of genomics knowledge and technologies. GAPP projects are collaborations between academic researchers and Receptor organizations and are funded by Genome Canada and co-funded by Receptors and other stakeholders. \nGenome BC staff will deliver a brief presentation on the competition followed by a Q&A session. Interested applicants will have the opportunity to have one-on-one conversations with Genome BC staff to help develop ideas. \nThe webinar will be delivered via Zoom and all interested UBC faculty\, support staff and partners are invited to attend. \nDetails: \n\nTuesday\, March 1\, 10-11:30am\nA Zoom link will be sent to registrants before the session\n\nGenome BC Contact: Alison Dendoff\nSPARC Contact: Alex Unterberger
URL:https://scienceinvancouver.com/event/genome-canada-genomic-applications-partnership-program-information-session-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220301T020000
DTEND;TZID=America/Vancouver:20220301T033000
DTSTAMP:20260619T050422
CREATED:20220222T210720Z
LAST-MODIFIED:20220222T210720Z
UID:28129-1646100000-1646105400@scienceinvancouver.com
SUMMARY:Genome Canada Genomic Applications Partnership Program Information Session
DESCRIPTION:The latest round of the Genome Canada Genomic Applications Partnership Program (GAPP) has launched and Genome BC\, in partnership with VPRI\, will host an Information Session in support of it. \nGAPP funds downstream research and development projects that address real world opportunities and challenges identified by industry\, government\, not-for-profits and other “Receptors” of genomics knowledge and technologies. GAPP projects are collaborations between academic researchers and Receptor organizations and are funded by Genome Canada and co-funded by Receptors and other stakeholders. \nGenome BC staff will deliver a brief presentation on the competition followed by a Q&A session. Interested applicants will have the opportunity to have one-on-one conversations with Genome BC staff to help develop ideas. \nThe webinar will be delivered via Zoom and all interested UBC faculty\, support staff and partners are invited to attend. \nDetails: \n\nTuesday\, March 1\, 10-11:30am\nA Zoom link will be sent to registrants before the session\n\nGenome BC Contact: Alison Dendoff\nSPARC Contact: Alex Unterberger
URL:https://scienceinvancouver.com/event/genome-canada-genomic-applications-partnership-program-information-session-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220301T020000
DTEND;TZID=America/Vancouver:20220301T033000
DTSTAMP:20260619T050422
CREATED:20220222T210720Z
LAST-MODIFIED:20220222T210720Z
UID:31212-1646100000-1646105400@scienceinvancouver.com
SUMMARY:Genome Canada Genomic Applications Partnership Program Information Session
DESCRIPTION:The latest round of the Genome Canada Genomic Applications Partnership Program (GAPP) has launched and Genome BC\, in partnership with VPRI\, will host an Information Session in support of it. \nGAPP funds downstream research and development projects that address real world opportunities and challenges identified by industry\, government\, not-for-profits and other “Receptors” of genomics knowledge and technologies. GAPP projects are collaborations between academic researchers and Receptor organizations and are funded by Genome Canada and co-funded by Receptors and other stakeholders. \nGenome BC staff will deliver a brief presentation on the competition followed by a Q&A session. Interested applicants will have the opportunity to have one-on-one conversations with Genome BC staff to help develop ideas. \nThe webinar will be delivered via Zoom and all interested UBC faculty\, support staff and partners are invited to attend. \nDetails: \n\nTuesday\, March 1\, 10-11:30am\nA Zoom link will be sent to registrants before the session\n\nGenome BC Contact: Alison Dendoff\nSPARC Contact: Alex Unterberger
URL:https://scienceinvancouver.com/event/genome-canada-genomic-applications-partnership-program-information-session-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220301T020000
DTEND;TZID=America/Vancouver:20220301T033000
DTSTAMP:20260619T050422
CREATED:20220222T210720Z
LAST-MODIFIED:20220222T210720Z
UID:32672-1646100000-1646105400@scienceinvancouver.com
SUMMARY:Genome Canada Genomic Applications Partnership Program Information Session
DESCRIPTION:The latest round of the Genome Canada Genomic Applications Partnership Program (GAPP) has launched and Genome BC\, in partnership with VPRI\, will host an Information Session in support of it. \nGAPP funds downstream research and development projects that address real world opportunities and challenges identified by industry\, government\, not-for-profits and other “Receptors” of genomics knowledge and technologies. GAPP projects are collaborations between academic researchers and Receptor organizations and are funded by Genome Canada and co-funded by Receptors and other stakeholders. \nGenome BC staff will deliver a brief presentation on the competition followed by a Q&A session. Interested applicants will have the opportunity to have one-on-one conversations with Genome BC staff to help develop ideas. \nThe webinar will be delivered via Zoom and all interested UBC faculty\, support staff and partners are invited to attend. \nDetails: \n\nTuesday\, March 1\, 10-11:30am\nA Zoom link will be sent to registrants before the session\n\nGenome BC Contact: Alison Dendoff\nSPARC Contact: Alex Unterberger
URL:https://scienceinvancouver.com/event/genome-canada-genomic-applications-partnership-program-information-session-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220301T100000
DTEND;TZID=America/Vancouver:20220301T160000
DTSTAMP:20260619T050422
CREATED:20220222T190155Z
LAST-MODIFIED:20220228T213419Z
UID:20892-1646128800-1646150400@scienceinvancouver.com
SUMMARY:UBC Faculty of Medicine 2022 Spring Virtual Research Showcase
DESCRIPTION:Faculty of Medicine is organizing the 2022 Spring Virtual Research Showcase on March 1\, 2022. This event will bring members of the Faculty of Medicine together to share and learn the diverse and innovative research work of graduate students\, fellows\, and recent senior faculty prize awardees. \nEvent Details:\nWhen: Tuesday\, March 1\, 2022\nTime: 10:00 AM– 4:00 PM PST\nWhere: Zoom Platform\n(link to be provided through email a day before the event to registered participants) \nRegistration Details:\nTo Register: Please click HERE. \nDeadline: Friday\, February 25\, 2022\, 5 PM PST \nIf you have general inquiries regarding this event\, please contact med.research@ubc.ca. \nEvent Highlights:\n\nKeynote addresses by Faculty of Medicine Distinguished Researcher Awardees Dr. Judy Illes and Dr. Michael Kobor.\nTalks by Students and Trainees highlighting current research at Faculty of Medicine
URL:https://scienceinvancouver.com/event/fom-2022-spring-virtual-research-showcase/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220301T100000
DTEND;TZID=America/Vancouver:20220301T160000
DTSTAMP:20260619T050422
CREATED:20220222T190155Z
LAST-MODIFIED:20220222T190155Z
UID:26511-1646128800-1646150400@scienceinvancouver.com
SUMMARY:UBC Faculty of Medicine 2022 Spring Virtual Research Showcase
DESCRIPTION:Faculty of Medicine is organizing the 2022 Spring Virtual Research Showcase on March 1\, 2022. This event will bring members of the Faculty of Medicine together to share and learn the diverse and innovative research work of graduate students\, fellows\, and recent senior faculty prize awardees. \nEvent Details:\nWhen: Tuesday\, March 1\, 2022\nTime: 10:00 AM– 4:00 PM PST\nWhere: Zoom Platform\n(link to be provided through email a day before the event to registered participants) \nRegistration Details:\nTo Register: Please click HERE. \nDeadline: Friday\, February 25\, 2022\, 5 PM PST \nIf you have general inquiries regarding this event\, please contact med.research@ubc.ca. \nEvent Highlights:\n\nKeynote addresses by Faculty of Medicine Distinguished Researcher Awardees Dr. Judy Illes and Dr. Michael Kobor.\nTalks by Students and Trainees highlighting current research at Faculty of Medicine
URL:https://scienceinvancouver.com/event/fom-2022-spring-virtual-research-showcase-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220301T100000
DTEND;TZID=America/Vancouver:20220301T160000
DTSTAMP:20260619T050422
CREATED:20220222T190155Z
LAST-MODIFIED:20220222T190155Z
UID:28126-1646128800-1646150400@scienceinvancouver.com
SUMMARY:UBC Faculty of Medicine 2022 Spring Virtual Research Showcase
DESCRIPTION:Faculty of Medicine is organizing the 2022 Spring Virtual Research Showcase on March 1\, 2022. This event will bring members of the Faculty of Medicine together to share and learn the diverse and innovative research work of graduate students\, fellows\, and recent senior faculty prize awardees. \nEvent Details:\nWhen: Tuesday\, March 1\, 2022\nTime: 10:00 AM– 4:00 PM PST\nWhere: Zoom Platform\n(link to be provided through email a day before the event to registered participants) \nRegistration Details:\nTo Register: Please click HERE. \nDeadline: Friday\, February 25\, 2022\, 5 PM PST \nIf you have general inquiries regarding this event\, please contact med.research@ubc.ca. \nEvent Highlights:\n\nKeynote addresses by Faculty of Medicine Distinguished Researcher Awardees Dr. Judy Illes and Dr. Michael Kobor.\nTalks by Students and Trainees highlighting current research at Faculty of Medicine
URL:https://scienceinvancouver.com/event/fom-2022-spring-virtual-research-showcase-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220301T100000
DTEND;TZID=America/Vancouver:20220301T160000
DTSTAMP:20260619T050422
CREATED:20220222T190155Z
LAST-MODIFIED:20220222T190155Z
UID:31209-1646128800-1646150400@scienceinvancouver.com
SUMMARY:UBC Faculty of Medicine 2022 Spring Virtual Research Showcase
DESCRIPTION:Faculty of Medicine is organizing the 2022 Spring Virtual Research Showcase on March 1\, 2022. This event will bring members of the Faculty of Medicine together to share and learn the diverse and innovative research work of graduate students\, fellows\, and recent senior faculty prize awardees. \nEvent Details:\nWhen: Tuesday\, March 1\, 2022\nTime: 10:00 AM– 4:00 PM PST\nWhere: Zoom Platform\n(link to be provided through email a day before the event to registered participants) \nRegistration Details:\nTo Register: Please click HERE. \nDeadline: Friday\, February 25\, 2022\, 5 PM PST \nIf you have general inquiries regarding this event\, please contact med.research@ubc.ca. \nEvent Highlights:\n\nKeynote addresses by Faculty of Medicine Distinguished Researcher Awardees Dr. Judy Illes and Dr. Michael Kobor.\nTalks by Students and Trainees highlighting current research at Faculty of Medicine
URL:https://scienceinvancouver.com/event/fom-2022-spring-virtual-research-showcase-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220301T100000
DTEND;TZID=America/Vancouver:20220301T160000
DTSTAMP:20260619T050422
CREATED:20220222T190155Z
LAST-MODIFIED:20220222T190155Z
UID:32669-1646128800-1646150400@scienceinvancouver.com
SUMMARY:UBC Faculty of Medicine 2022 Spring Virtual Research Showcase
DESCRIPTION:Faculty of Medicine is organizing the 2022 Spring Virtual Research Showcase on March 1\, 2022. This event will bring members of the Faculty of Medicine together to share and learn the diverse and innovative research work of graduate students\, fellows\, and recent senior faculty prize awardees. \nEvent Details:\nWhen: Tuesday\, March 1\, 2022\nTime: 10:00 AM– 4:00 PM PST\nWhere: Zoom Platform\n(link to be provided through email a day before the event to registered participants) \nRegistration Details:\nTo Register: Please click HERE. \nDeadline: Friday\, February 25\, 2022\, 5 PM PST \nIf you have general inquiries regarding this event\, please contact med.research@ubc.ca. \nEvent Highlights:\n\nKeynote addresses by Faculty of Medicine Distinguished Researcher Awardees Dr. Judy Illes and Dr. Michael Kobor.\nTalks by Students and Trainees highlighting current research at Faculty of Medicine
URL:https://scienceinvancouver.com/event/fom-2022-spring-virtual-research-showcase-5/
LOCATION:Online
END:VEVENT
END:VCALENDAR